あすか製薬ホールディングス(株)の貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証PRM | 医薬品 | 4886/ - | - |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2023/01/27 | 日証協 | 208,065株 | -0.23% | 813株 | -13.97% | 243,140株 | -3.49% | 8,204株 | +2.88% |
2023/01/20 | 日証協 | 208,552株 | -3.41% | 945株 | -34.65% | 251,927株 | -1.45% | 7,974株 | -70.22% |
2023/01/13 | 日証協 | 215,921株 | -5.83% | 1,446株 | -80.29% | 255,640株 | +3.91% | 26,778株 | +9.51% |
2023/01/06 | 日証協 | 229,283株 | +0.71% | 7,338株 | -94.96% | 246,016株 | +2.12% | 24,453株 | +94.33% |
2022/12/30 | 日証協 | 227,676株 | +145.93% | 145,726株 | +230.9% | 240,916株 | -0.66% | 12,583株 | -89.53% |
2022/12/23 | 日証協 | 92,576株 | -35.9% | 44,039株 | +197.06% | 242,516株 | +5.21% | 120,166株 | +650.38% |
2022/12/16 | 日証協 | 144,428株 | -3.86% | 14,825株 | -4.43% | 230,516株 | -0.82% | 16,014株 | -41.09% |
2022/12/09 | 日証協 | 150,228株 | +2.21% | 15,513株 | -56.56% | 232,432株 | +3.56% | 27,183株 | +13.82% |
2022/12/02 | 日証協 | 146,978株 | -11.95% | 35,713株 | -44.03% | 224,449株 | +0.91% | 23,883株 | +10.56% |
2022/11/18 | 日証協 | 128,828株 | +5.01% | 43,087株 | -2.61% | 215,331株 | +1.65% | 13,383株 | +21.85% |
2022/11/11 | 日証協 | 122,677株 | -1.57% | 44,242株 | -24.26% | 211,839株 | -0.47% | 10,983株 | -58.68% |
2022/11/04 | 日証協 | 124,628株 | +10.7% | 58,410株 | +58.61% | 212,840株 | +7.63% | 26,583株 | +121.84% |
2022/10/28 | 日証協 | 112,577株 | -5.46% | 36,826株 | +8.22% | 197,757株 | -3.93% | 11,983株 | +49.79% |
2022/10/21 | 日証協 | 119,077株 | -6% | 34,029株 | -64.11% | 205,851株 | -3.02% | 8,000株 | -34.89% |
2022/10/14 | 日証協 | 126,677株 | +78.04% | 94,815株 | +33.92% | 212,264株 | -0.69% | 12,286株 | -76.51% |
2022/10/07 | 日証協 | 71,152株 | +26.04% | 70,800株 | -9% | 213,747株 | +134.11% | 52,304株 | -76.45% |
2022/09/30 | 日証協 | 56,452株 | -57.92% | 77,804株 | +34.4% | 91,303株 | -59.51% | 222,092株 | +1064.37% |
2022/09/22 | 日証協 | 134,143株 | -5.24% | 57,888株 | -31.1% | 225,523株 | +0.53% | 19,074株 | -4.55% |
2022/09/16 | 日証協 | 141,567株 | -11.78% | 84,012株 | +14.48% | 224,332株 | -5.53% | 19,983株 | -70.17% |
※株式分割は考慮していませんのでご注意ください。
Page Top